药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bismuth subsalicylate
Penfluridol
Regorafenib may increase the bradycardic activities of Penfluridol.
Bismuth subsalicylate
Lidoflazine
Regorafenib may increase the bradycardic activities of Lidoflazine.
Bismuth subsalicylate
Terodiline
Regorafenib may increase the bradycardic activities of Terodiline.
Bismuth subsalicylate
Otilonium
Regorafenib may increase the bradycardic activities of Otilonium.
Bismuth subsalicylate
Bencyclane
Regorafenib may increase the bradycardic activities of Bencyclane.
Bismuth subsalicylate
Vinpocetine
Regorafenib may increase the bradycardic activities of Vinpocetine.
Bismuth subsalicylate
Tetrahydropalmatine
Regorafenib may increase the bradycardic activities of Tetrahydropalmatine.
Bismuth subsalicylate
Naftopidil
Regorafenib may increase the bradycardic activities of Naftopidil.
Bismuth subsalicylate
Carboxyamidotriazole
Regorafenib may increase the bradycardic activities of Carboxyamidotriazole.
Bismuth subsalicylate
Niludipine
Regorafenib may increase the bradycardic activities of Niludipine.
Bismuth subsalicylate
Lacidipine
Regorafenib may increase the bradycardic activities of Lacidipine.
Bismuth subsalicylate
Darodipine
Regorafenib may increase the bradycardic activities of Darodipine.
Bismuth subsalicylate
Cilnidipine
Regorafenib may increase the bradycardic activities of Cilnidipine.
Bismuth subsalicylate
Azelnidipine
Regorafenib may increase the bradycardic activities of Azelnidipine.
Bismuth subsalicylate
Aranidipine
Regorafenib may increase the bradycardic activities of Aranidipine.
Bismuth subsalicylate
Tolfenamic acid
Regorafenib may increase the bradycardic activities of Tolfenamic acid.
Bismuth subsalicylate
Pinaverium
Regorafenib may increase the bradycardic activities of Pinaverium.
Bismuth subsalicylate
Trimebutine
Regorafenib may increase the bradycardic activities of Trimebutine.
Bismuth subsalicylate
Eperisone
Regorafenib may increase the bradycardic activities of Eperisone.
Bismuth subsalicylate
Fendiline
Regorafenib may increase the bradycardic activities of Fendiline.